How long should I take brigatinib?

The duration of treatment with Brigatinib (Brigatinib) varies based on the patient's specific condition. Typically, brigatinib is a drug that is taken long-term until the disease progresses or the patient cannot tolerate the drug. The initial treatment phase is generally 90 mg once daily for 7 days. If the patient is able to tolerate this dose, the doctor will increase the dose to 180 mg once daily, which is the usual dose for maintenance therapy.

Patients will need regular medical examinations during treatment with brigatinib . These tests include imaging tests, blood tests, and electrocardiograms to evaluate the effectiveness of the drug and monitor potential adverse reactions. Based on the test results, the doctor may adjust the drug dosage to ensure the best therapeutic effect and patient safety. If serious side effects occur, your doctor may temporarily stop or permanently stop your use of brigatinib (brigatinib).

Continuous use of brigatinib is critical to controlling disease progression and prolonging patient survival. Studies have shown that long-term use of brigatinib can significantly delay the progression of ALK-positive non-small cell lung cancer and improve patients' quality of life. Even when your disease is stable or in remission, continuing to take brigatinib (brigatinib) can help prevent the cancer from coming back or spreading further. Therefore, unless there is a clear medical reason, patients should continue to take brigatinib as directed by their doctor.

Treatment regimens with brigatinib should be individually tailored to the patient's specific circumstances. The patient's health, severity of illness, response to the drug, and possible adverse reactions may affect when and how much brigatinib should be taken. During the treatment process, the doctor will work closely with the patient to regularly evaluate the treatment effect and adjust the treatment plan as needed. Patients should actively communicate with their doctors and report any discomfort or abnormalities so that treatment strategies can be adjusted in a timely manner to ensure the best treatment effect and safety.